Lipum AB (publ)
556813-5999InactiveDeveloping first-in-class antibody drug candidate for chronic inflammatory diseases.
Oversikt
- 5–9
- Ansatte
- 750–999t SEK
- Omsetning
- 2010
- Grunnlagt
Nøkkelbeslutningstakere
Ola Sandborgh
CEO
Beskrivelse
Lipum AB (publ) is a clinical-phase biopharmaceutical company focused on developing novel treatments for chronic inflammatory diseases. Their lead drug candidate is SOL-116, a humanized monoclonal antibody designed to offer a unique mechanism of action. SOL-116 targets the Bile Salt-Stimulated Lipas...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556813599901
Beslutningstakere
1 kontakter i FunnelfeedrOla Sandborgh
CEO
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrLipigon Pharmaceuticals AB
5–9 ansatteClinical-stage company developing novel drugs for lipid disorders.
SynAct Pharma AB
5–9 ansatteClinical-stage biotech resolving inflammation via novel oral therapies.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
AQILION AB
5–9 ansatteDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Transient Pharma AB
0 ansatteDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Utforsk mer
Spørsmål om Lipum AB (publ)
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo